Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Creso Pharma Limited
  6. News
  7. Summary
    CPH   AU000000CPH2

CRESO PHARMA LIMITED

(CPH)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Creso Pharma : Canadian Subsidiary to Introduce 14 New Pot Strains

07/30/2021 | 02:19am EDT


© MT Newswires 2021
All news about CRESO PHARMA LIMITED
09/16CRESO PHARMA : Unveils New e-Commerce Channels for Deeper Reach into European Ma..
MT
09/16Creso Pharma Limited Launches New E-Commerce Channels
CI
09/13CRESO PHARMA : Secures Two Purchase Orders from Swiss Import-Export Partner; Sha..
MT
09/12Creso Pharma Limited Secures New Purchase Orders for Human Health Products
CI
09/05Creso Pharma Limited Announces Executive Changes
CI
08/31Creso Pharma Limited Reports Earnings Results for the Half Year Ended June 30..
CI
08/30RED LIGHT HOLLAND : Creso Pharma Agree to Terminate Merger; Falls 1.9%
MT
08/30Creso Pharma Limited cancelled the acquisition of Red Light Holland Corp. in ..
CI
07/30CRESO PHARMA : Canadian Subsidiary to Introduce 14 New Pot Strains
MT
07/23CRESO PHARMA : Halucenex Life Sciences Taps Landing Strong for Support Service i..
MT
More news
Financials
Sales 2020 2,45 M 1,78 M 1,78 M
Net income 2020 -30,8 M -22,4 M -22,4 M
Net cash 2020 2,79 M 2,03 M 2,03 M
P/E ratio 2020 -2,17x
Yield 2020 -
Capitalization 144 M 105 M 105 M
EV / Sales 2019 6,12x
EV / Sales 2020 65,2x
Nbr of Employees -
Free-Float 87,4%
Chart CRESO PHARMA LIMITED
Duration : Period :
Creso Pharma Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CRESO PHARMA LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBullish
Income Statement Evolution
Managers and Directors
Chris Grundy Chief Financial Officer
Adam Blumenthal Non-Executive Chairman
Carole Abel Director-Commercial Operations
Boaz Wachtel Non-Executive Director
James Anthony Ellingford Executive Director
Sector and Competitors
1st jan.Capi. (M$)
CRESO PHARMA LIMITED-33.33%105
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.20.81%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604